Instil Bio, Inc. TIL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | -- | 27.22M | 31.53M | 36.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 51.96M | 53.87M | 50.12M |
| Operating Income | -- | -- | -51.96M | -53.87M | -50.12M |
| Income Before Tax | -- | -- | -71.37M | -75.08M | -84.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -71.37 | -75.08 | -84.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -71.37M | -75.08M | -84.51M |
| EBIT | -- | -- | -51.96M | -53.87M | -50.12M |
| EBITDA | -- | -- | -51.43M | -52.61M | -47.97M |
| EPS Basic | -- | -- | -10.78 | -11.39 | -12.92 |
| Normalized Basic EPS | -- | -- | -4.20 | -4.55 | -4.32 |
| EPS Diluted | -- | -- | -10.78 | -11.39 | -12.92 |
| Normalized Diluted EPS | -- | -- | -4.20 | -4.55 | -4.32 |
| Average Basic Shares Outstanding | -- | -- | 26.67M | 26.41M | 26.16M |
| Average Diluted Shares Outstanding | -- | -- | 26.67M | 26.41M | 26.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |